Trials / Completed
CompletedNCT07272330
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
A Phase I Study to Evaluate the Relative Bioavailability of Different HRS-1893 Formulations and the Effect of Food on the Pharmacokinetics of HRS-1893 Tablets in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This Phase I clinical trial will investigate the relative bioavailability between two formulations of HRS-1893 tablets and the influence of food on the drug's pharmacokinetics in healthy adult participants. The safety and tolerability of HRS-1893 will also be monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1893 tablet A | Specified dose on specified days. |
| DRUG | HRS-1893 tablet B | Specified dose on specified days. |
Timeline
- Start date
- 2025-12-11
- Primary completion
- 2026-03-21
- Completion
- 2026-03-21
- First posted
- 2025-12-09
- Last updated
- 2026-04-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07272330. Inclusion in this directory is not an endorsement.